Status:
ACTIVE_NOT_RECRUITING
Healthy Human Control Blood Collection for Validation of Biomarker Assay
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Healthy
Eligibility:
All Genders
18-60 years
Brief Summary
Human blood will be collected to serve as control in validating clinical studies studying the detection and levels of circulating tumor cells and microvesicles in cancer patients. Targeted population ...
Eligibility Criteria
Inclusion
- Age range: 18-60 years old Gender: Male and Female
Exclusion
- No previously diagnosed malignancy Age: It is important to obtain a healthy, cancer-free volunteer population to serve as negative controls for this detection assay.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT02302885
Start Date
November 1 2014
End Date
December 1 2025
Last Update
January 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104